CRSP growth curveHolding shares of CRSP in the long term. Imagine investing in Walmart or some shit. Listening to Cathie Wood and Jennifer Doudna talk about Genomics and Crisper. Insane.
0VRQ trade ideas
Break out from a continuation pattern NASDAQ:CRSP Continuation wedge after a big break out. The trading range has got very tight with buyers and sellers starting to agree on the current price. Potential
buy through 152.5 against 147.
CRSP Bullish Trade Setup CRISPR is on our watchlist is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Look to establish longs with dips into 124 Tier 1 and then 115 Tier 2.
CRSP - Bull PennantCRSP was on a roll since it broke out of consolidation range (>112) on Nov 27. It started to form a bull pennant for the past week giving late comers an opportunity to stake.
There are 2 possible entries we can consider. The traditional way is to enter upon the break up of the bull pennant (this way the trade will almost always go our way). However, I do not mind entering at the lower end of the pennant (could mean longer wait before we see a good move).
Either way, I would still place a stop loss abt $1 below the pennant low of 138. Trail it upwards once we have a reasonable profit.
We do not know how high it can go eventually hence trail your stops upward (giving enough room to swing) or take partial profits along the way up.
Stock to watch: Crispr Therapeutics AG (CRSP) - re-uploadNASDAQ:CRSP
Re-uploading the original idea from Nov 24 (which was brutally deleted by the moderators LOL) 👇🏻
Original chart from Nov 24
May be an interesting stock to trade: Buy/Sell Zones indicates a 20-day uptrend. Long-term target is 1 Fibonacci, short-term targets may be lower Fibonacci values. The pre-market shows a small potential recoil that can give a good Long entry point.
Disclaimer: This article should not be considered as financial or investment advice. Trading digital assets involve risk and may resolve in the loss of your capital. Always be sure to understand the amount of risk involved and do your research before taking any trading/investment steps.
Re-visit my earlier call about CRSP/NTLA/EDITTo my followers;
I made a call about these 3 companies couple of months back. Since then they have some good runs and the momentum seems to be getting even stronger.
Check out this interview with Ms. Cathie Wood, founder and CEO of Ark Invest, about their technologies.
www.youtube.com
Personally I am holding some positions in these companies and looking for keep adding to it when time is right.
Disclaimer, this is only for entertainment and education purposes and doesn't serve by any means as a buy or sell recommendation.
Personally I hold both long term long positions and occasionally short term short position, for disclosure purpose.
$CRSP - target at $127Call option on CRSP - target is right under $127, then reevaluate for next entry
$CRSP - will it follow the 1,2,3 pattern? $SBUX followed the pattern to a tee - missed my own prediction on that one.
Watching $CRSP for entry around the 20 EMA to ride into 3rd attempt at breaking resistance.
ABC BullishKnown to be volatile. Just when you think you have it, a deep pull back lands on you like a bad dream
But you never know, do we?
Possible stop at 83.35 or below. On this one I would use a stop
Has just about met targets 1 and monthly candle is bullish
Not overbought
NV and OBV are high
Short interest is higher than I like.
I see S at long entry level
No rising wedges in yearly chart
Be safe on this one and good luck
Possible ABC correction scenario - moving on technicalsIt appears that this name is now moving based on technicals - I have outlined a possible impulse ABC correction scenario as we've seemed to have recently finished wave 5 of the Elliott Impulse. Fib retracement supports have been plotted to show possible retracement support levels.
CRSP Long IdeaAfter consolidating in this $80-$90 range for a couple months they finally got a price upgrade to 115. I think we could potentially be in the beginning of a bigger wave 3 of Elliot Wave Theory. I have a tight stop loss of the gap being filled and breaking down from there.
CRSP buy Initiate a small position and look for adding more on pullbacks.
Beta 2.3
Disclaimer, this is only for entertainment and education purposes and doesn't serve by any means as a buy or sell recommendation.
Personally I hold both long term long positions and occasionally short term short position, for disclosure purpose.
the next pton type play?i love the green ;) id keep a long position as long as 100-105 holds as support. will watch for entry next week
Closed above previous daily resistance of $100.77 - PT $114Closed above the previous daily resistance of $100.77 - approach next fib extension to $114 area. Strong and long on this bullish flag break out.
Cup and Handle Patterns above PatternsAnother cup and handle has formed above the old cup and handle
If you enjoy volatility this is a good one for you. This one may pull back again close to handle low of new cup and handle
Remains to be seen
Be patient and pick a good entry that works for you
Stop to your tolerance or below handle low
The last time this one reached long entry, iit did not hold on to the high.
Deep pull back ensued and now CRSP seems to have energy again
I see now a new all time high was just made but has pulled back again.
If you like this stock, beware of volatility
It appears Gene editing companies are hot as of late/TXG is another
NV is high and short interest is mediocre but a bit higher than I like
Be safe and be patient (o:
Not a recommendation
CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious human diseases. It develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), a gene editing technology that allows for precise directed changes to genomic DNA. It has a portfolio of therapeutic programs in a range of disease areas, including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company's lead product candidate is CTX001, an ex vivo CRISPR gene-edited therapy for treating patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce high levels of fetal hemoglobin in red blood cells. It is also developing CTX110, a donor-derived gene-edited allogeneic CAR-T therapy targeting cluster of differentiation 19 positive malignancies. In addition, the company is developing allogeneic CAR-T programs comprising CTX120 targeting B-cell maturation antigen for the treatment of multiple myeloma; and CTX130 for the treatment of solid tumors and hematologic malignancies. Further, it engages in developing regenerative medicine programs in diabetes; and in vivo and other genetic disease programs to treat glycogen storage disease Ia, Duchenne muscular dystrophy, and cystic fibrosis. The company has strategic partnerships with Bayer Healthcare LLC, Vertex Pharmaceuticals Incorporated, and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland.
Solid daily green candle so far halfway into the day's session!Will there be more upside? Plan your trades and trade your plans. Trade responsibly. Cheers and congrats to those who followed me in on this trade!
Consolidation and flagging - PT $115 at the 1.618 Fib extensionCRSP had a recent pop due to the Nobel prize announcement - after a little pullback and consolidation at these levels, it looks getting poised again to reach ATHs. Long price target $115 minimum. A great fundamental and technical set up. ARKK ETF's #2 position in their portfolio. A great disruptor in the genomics sector.
